Cathy Ndiaye1, Laia Alemany, Nafissatou Ndiaye, Bakarou Kamaté, Yankhoba Diop, Michael Odida, Kunbi Banjo, Sara Tous, Jo Ellen Klaustermeier, Omar Clavero, Xavier Castellsagué, F Xavier Bosch, Helen Trottier, Silvia de Sanjosé. 1. Department of Social and Preventive Medicine, Université de Montréal, Montreal, QC, Canada Sainte-Justine Hospital Research Center, Montreal, QC, Canada Unit of Infections and Cancer, Institut Català d'Oncologia, Barcelona, Spain CIBER Epidemiología y Salud Pública, CIBERESP, Barcelona, Spain Université Cheikh Anta Diop, Dakar, Senegal Faculté de Médecine, Université de Bamako, Bamako, Mali Hôpital Principal de Dakar, Dakar, Senegal Department of Pathology, School of Biomedical Sciences, Makerere University, Kampala, Uganda Lagos University Teaching Hospital Idi-Araba, Lagos, Nigeria Red Temàtica de Investigaciòn Cooperativa en Càncer, RTICC, Barcelona, Spain.
Abstract
OBJECTIVES: To describe human papillomavirus (HPV) distribution in invasive cervical carcinoma (ICC) from Mali and Senegal and to compare type-specific relative contribution among sub-Saharan African (SSA) countries. METHODS: A multicentric study was conducted to collect paraffin-embedded blocks of ICC. Polymerase chain reaction, DNA enzyme immunoassay and line probe assay were performed for HPV detection and genotyping. Data from SSA (Mozambique, Nigeria and Uganda) and 35 other countries were compared. RESULTS: One hundred and sixty-four ICC cases from Mali and Senegal were tested from which 138 were positive (adjusted prevalence = 86.8%; 95% CI = 79.7-91.7%). HPV16 and HPV18 accounted for 57.2% of infections and HPV45 for 16.7%. In SSA countries, HPV16 was less frequent than in the rest of the world (49.4%vs. 62.6%; P < 0.0001) but HPV18 and HPV45 were two times more frequent (19.3%vs. 9.4%; P < 0.0001 and 10.3%vs. 5.6%; P < 0.0001, respectively). There was an ecological correlation between HIV prevalence and the increase of HPV18 and the decrease of HPV45 in ICC in SSA (P = 0.037 for both). CONCLUSION: HPV16/18/45 accounted for two-thirds of the HPV types found in invasive cervical cancer in Mali and Senegal. Our results suggest that HIV may play a role in the underlying HPV18 and HPV45 contribution to cervical cancer, but further studies are needed to confirm this correlation.
OBJECTIVES: To describe human papillomavirus (HPV) distribution in invasive cervical carcinoma (ICC) from Mali and Senegal and to compare type-specific relative contribution among sub-Saharan African (SSA) countries. METHODS: A multicentric study was conducted to collect paraffin-embedded blocks of ICC. Polymerase chain reaction, DNA enzyme immunoassay and line probe assay were performed for HPV detection and genotyping. Data from SSA (Mozambique, Nigeria and Uganda) and 35 other countries were compared. RESULTS: One hundred and sixty-four ICC cases from Mali and Senegal were tested from which 138 were positive (adjusted prevalence = 86.8%; 95% CI = 79.7-91.7%). HPV16 and HPV18 accounted for 57.2% of infections and HPV45 for 16.7%. In SSA countries, HPV16 was less frequent than in the rest of the world (49.4%vs. 62.6%; P < 0.0001) but HPV18 and HPV45 were two times more frequent (19.3%vs. 9.4%; P < 0.0001 and 10.3%vs. 5.6%; P < 0.0001, respectively). There was an ecological correlation between HIV prevalence and the increase of HPV18 and the decrease of HPV45 in ICC in SSA (P = 0.037 for both). CONCLUSION:HPV16/18/45 accounted for two-thirds of the HPV types found in invasive cervical cancer in Mali and Senegal. Our results suggest that HIV may play a role in the underlying HPV18 and HPV45 contribution to cervical cancer, but further studies are needed to confirm this correlation.
Keywords:
Afrique subsaharienne; HIV; VIH; Virus del Papiloma Humano; Virus du papillome humain; cancer du col de l’utérus; cervical cancer; cáncer cervical; distribución de genotipos; distribution des génotypes; genotype distribution; human papillomavirus; sub‐Saharan Africa; África subsahariana
Authors: Pragna Patel; Charles E Rose; Pamela Y Collins; Bernardo Nuche-Berenguer; Vikrant V Sahasrabuddhe; Emmanuel Peprah; Susan Vorkoper; Sonak D Pastakia; Dianne Rausch; Naomi S Levitt Journal: AIDS Date: 2018-07-01 Impact factor: 4.177
Authors: Washington Mudini; Joel M Palefsky; Martin J Hale; Michael Z Chirenje; Rudo Makunike-Mutasa; Fiona Mutisi; Alltalents Murahwa; Altini Mario Journal: J Acquir Immune Defic Syndr Date: 2018-09-01 Impact factor: 3.731
Authors: Rebecca Kemunto Ogembo; Philimon Nyakauru Gona; Alaina J Seymour; Henry Soo-Min Park; Paul A Bain; Louise Maranda; Javier Gordon Ogembo Journal: PLoS One Date: 2015-04-14 Impact factor: 3.240
Authors: Anthony Mwololo; Joshua Nyagol; Emily Rogena; Willis Ochuk; Mary Kimani; Noel Onyango; Lorenzo Pacenti; Rosa Santopietro; Lorenzo Leoncini; Walter Mwanda Journal: Infect Agent Cancer Date: 2014-02-26 Impact factor: 2.965
Authors: Sally N Akarolo-Anthony; Maryam Al-Mujtaba; Ayotunde O Famooto; Eileen O Dareng; Olayinka B Olaniyan; Richard Offiong; Cosette M Wheeler; Clement A Adebamowo Journal: BMC Infect Dis Date: 2013-11-05 Impact factor: 3.090